Prognostic significance of the residual SYNTAX score after coronary stenting
Authors:
Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Original articles
DOI:
For citation: Keren M.A., Sigaev I.Yu, Zakrevsky E.L., Yakhyaeva K.B., Odisharia N.T., Musaev M.K., Zavalikhina T.V., Klyuchnikov I.V., Volkovskaya I.V., Avakova S.A. Prognostic significance of residual SYNTAX score after coronary stenting. Creative Cardiology. 2026; 20 (2): 257–266 (in Russ.). DOI: 10.24022/1997-3187-2026-20-2-257-266
Received / Accepted: 10.03.2026 / 08.05.2026
Keywords: coronary artery disease percutaneous coronary stenting SYNTAX score multivessel coronary artery disease
Abstract
Aim. To assess the prognostic significance of the residual SYNTAX score in patients with coronary artery disease (CAD) and multivessel disease following percutaneous coronary intervention (PCI).
Material and Methods. This retrospective study included 197 patients with CAD and multivessel coronary artery (CA) disease who underwent elective PCI. The baseline SYNTAX score, residual SYNTAX score, and the mean change in score before and after PCI (Δ SYNTAX) were calculated for all patients. The mean follow-up period was 76.7 (73.9–79.5) months. The study endpoints were all-cause death (from any cause) and cardiovascular death occurring during the follow- up period of up to 7 years after the intervention.
Results. In patients with CAD referred for elective PCI, there is a strong positive correlation (ρ=0.756, p<0.001) between baseline and residual SYNTAX scores. A high residual SYNTAX score is associated with high comorbidity burden and increased anatomical procedural risks due to a high incidence of three-vessel CA disease combined with left main coronary artery (LMCA) disease, as well as CA occlusion. A residual SYNTAX score >10 after PCI is associated with an increased risk of all-cause (OR 2.595 (95% CI 1.258–5.355), p=0.010) and cardiovascular mortality (OR 3.792 (95% CI 1.267– 1.352), p=0.017). Groups with residual SYNTAX scores of 0–5 and 6–10 showed no statistically significant differences in long-term survival.
Conclusion. A residual SYNTAX score >10 is associated with an increased risk of all-cause (OR 2.595 (95% CI 1.258– 5.355), p=0.010) and cardiovascular mortality (OR 3.792 (95% CI 1.267–1.352), p=0.017). A residual SYNTAX 0 to 10 after PCI is associated with a low risk profile for long-term mortality.
References
- Clinical practice guidelines 2024 for Stable coronary artery disease. Russian Journal of Cardiology. 2024; 29 (9): 6110 (in Russ.). DOI: 10.15829/1560-4071-2024-6110. EDN: HHJJUT.
- Golukhova E.Z., Sigaev I.Yu., Keren M.A. et al. Comparison of coronary artery bypass grafting and stenting depending on the clinical and anatomical scenario: data from the retrospective single-center cohort study. Russian Journal of Cardiology. 2025; 30 (4): 6092 (in Russ.). DOI: 10.15829/1560-4071-2025-6092.
- Golukhova E.Z., Keren M.A., Zavalikhina T.V. et al. Prognosis of Early Outcomes after Isolated Coronary Bypass Surgery: Results of a Single-Center Cohort Study. Annals of the Russian Academy of Medical Sciences. 2023; 78 (3): 176–184 (in Russ.). DOI: 10.15690/vramn8086.
- Sigaev I.Yu., Keren M.A. Indications, criteria, choice of the method of myocardial revascularization: European and Russian clinical guidelines data. Creative Cardiology. 2018; 12 (2): 167–176 (in Russ.). DOI: 10.24022/1997-3187-2018-12-2-167-176.
- Keren M.A., Kazaryan A.V. Recurrent ischemia after myocardial revascularization: the current state of the problem, risk factors, prognosis, tactics and results of repeated interventions. Annals of Surgery. 2017; 22 (5): 257–264 (in Russ.). DOI: 10.18821/1560-9502-2017-22-5-257-264.
- Nagaraja V., Ooi S.Y., Nolan J. et al. Impact of incomplete percutaneous revascularization in patients with multivessel coronary artery disease: a systematic review and meta-analysis. Journal of the American Heart Association. 2016; 5 (12): e004598. DOI: 10.1161/JAHA.116.004598.
- Gaba P., Gersh B.J., Ali Z.A. et al. Complete versus incomplete coronary revascularization: definitions, assessment and outcomes. Nature Reviews Cardiology. 2021; 18 (3): 155–168. DOI: 10.1038/s41569-020-00457-5.
- Serruys P.W., Onuma Y., Garg S. et al. Assessment of the SYNTAX score in the SYNTAX study. EuroIntervention. 2009; 5 (1): 50–56. DOI: 10.4244/EIJV5I1A9.
- Généreux P., Palmerini T., Caixeta A. et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. Journal of the American College of Cardiology. 2012; 59: 2165–2174.
- Farooq V., Serruys P.W., Bourantas C.V. et al. Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial: validation of the residual SYNTAX score. Circulation. 2013; 128 (2): 141–151. DOI: 10.1161/CIRCULATIONAHA.113.001803.
- Alidoosti M., Saroukhani S., Lotfi-Tokaldany M. et al. Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease. Cardiovascular Revascularization Medicine. 2016; 17 (5): 308–312. DOI: 10.1016/j.carrev.2016.03.009.
- Yan L., Li P., Wang Y. et al. The Incremental Prognostic Value of the Clinical Residual SYNTAX Score for Patients With Chronic Renal Insufficiency Undergoing Percutaneous Coronary Intervention. Frontiers in Cardiovascular Medicine. 2021; 8: 647720. DOI: 10.3389/fcvm.2021.647720.
- Satheesh S., Kumar R., Pillai A.A., Selvaraj R. Prognostic value of residual SYNTAX score in patients with coronary artery disease undergoing percutaneous coronary intervention: cohort study. Indian Heart Journal. 2024; 76 (3): 221–223. DOI: 10.1016/j.ihj.2024.06.006.
- https://www.syntaxscore.org/calculator/start.htm
- Généreux P., Campos C.M., Farooq V. et al. Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention. American Journal of Cardiology. 2015; 116 (2): 174–186. DOI: 10.1016/j.amjcard.2015.03.056.
- Choi K.H., Lee J.M., Koo B.K. et al. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease. JACC: Cardiovascular Interventions. 2018; 11 (3): 237–245. DOI: 10.1016/j.jcin.2017.09.009.
- Keren M.A., Sigaev I.Yu., Osipova A.I. et al. Impact of chronic kidney disease on type of coronary artery bypass grafting and on the structure of postoperative complications in patients with coronary artery disease. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2023; 65 (4): 414–423 (in Russ.). DOI: 10.24022/0236-2791-2023-65-4-414-423.
- Li C., Li J.Y., Feng D.J. et al. Holistic review and meta-analysis of independent impact of the residual SYNTAX score on prognosis in patients with acute coronary syndrome. Scandinavian Cardiovascular Journal. 2022; 56 (1): 187–197. DOI: 10.1080/14017431.2022.2095434.
- Yarbekov R.R., Chigogidze N.A., Sigaev I.Yu., Keren M.A. The early and mid-term results of percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease. Annals of Surgery. 2014; 5: 21–26 (in Russ.).
- Sigaev I.Yu., Keren M.A., Slivneva I.V. et al. The algorithm for using transit-time flow measurement and high-resolution epicardial ultrasound for intraoperative graft assessment during coronary artery bypass surgery. Kardiologiia. 2022; 62 (6): 3–10 (in Russ.). DOI: 10.18087/cardio.2022.8.n1823.
- Sigaev I.Yu., Keren M.A., Kazaryan A.V. et al. Subclavian-coronary bypass graft re-operation according to the MICS technique in a patient with angina relapse. Russian Journal of Cardiology. 2019; 8: 94–96 (in Russ.). DOI: 10.15829/1560-4071-2019-8-94-96.
- Petrosyan K.V., Abrosimov A.V., Goncharova E.S. Assessing coronary blood flow physiology in the modern strategy of coronary artery disease catheterization treatment. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 66 (3): 270–281 (in Russ.). DOI: 10.24022/0236-2791-2024-66-3-270-281.
About Authors
- Milena A. Keren, Рrofessor; ORCID
- Igor Yu. Sigaev, Dr. Med. Sci., Professor, Head of the Department of Surgery for Combined Diseases of the Coronary and Major Arteries, Director of the Institute of Coronary and Vascular Surgery; ORCID
- Efim L. Zakrevsky, Postgraduate, Cardiologist; ORCID
- Kumushdzhan B. Yakhyaeva, Junior Researcher, Cardiologist; ORCID
- Naum T. Odisharia, Cand. Med. Sci., Endovascular Surgeon; ORCID
- Magomedrasul K. Musaev, Cand. Med. Sci., Acting Head of Department, Endovascular Surgeon; ORCID
- Tatyana V. Zavalikhina, Cand. Med. Sci., Chief Physician of the Institute of Coronary and Vascular Surgery; ORCID
- Ivan V. Klyuchnikov, Dr. Med. Sci., Professor, Chief Researcher, Cardiologist; ORCID
- Irina V. Volkovskaya, Cand. Med. Sci., Head of Department; ORCID
- Susanna A. Avakova, Cand. Med. Sci., Head of Department; ORCID


